Drug Security Forum

National Drug Policy: The Road to Russian Sovereignty

14 Jun , 16:30–18:00
‘Ensuring Drug Security’ Russian Pharmaceutical Forum
Plenary session
Congress Centre, zone D, conference hall D1

Today, in a time of geopolitical challenges, the role of national drug policy in the country’s economic security strategy is becoming critically important. One of the priorities for government policy on the regulation of the use of medicines and medical devices is to produce drugs – primarily those from the list of vital and essential drugs (VED) and drugs of strategic importance – without being dependent on imports. Industry players are faced with the task of ensuring drug sovereignty in the country at all stages of production, from intermediates for the production of pharmaceutical substances to the full-scale roll-out of innovative import substitution of drugs in Russia using modern developments and cutting-edge scientific discoveries. Since destabilizing foreign economic pressure began to take effect, effective measures of state support for the Russian pharmaceutical industry were promptly devised, and today efforts should be focused not only on developing a roadmap for achieving sustainable national technological sovereignty, but also on strengthening the country’s export potential, and increasing the presence of competitive, original Russian drugs on international markets. Which regulatory policies have helped the pharmaceutical industry to withstand the sanctions and ensure an uninterrupted supply of strategically important medicines? What kind of challenges does the pharmaceutical supply system face today, and which strategies can counter them? What government incentives can make it easier to achieve sovereignty in the timeframe required under the sanctions? In the current environment, how may we boost provision of groundbreaking drugs to the market and strengthen the export potential of the Russian pharmaceutical industry?

Welcome Remark
Galina Karelova, Deputy Chairman, Federation Council of the Federal Assembly of the Russian Federation

Evelina Zakamskaya, Chief Editor, Doctor TV Channel

Sergey Glagolev, Deputy Minister of Health of the Russian Federation
Aleksandr Petrov, Head of the Expert Council for Regulating the Circulation of Medicines and Medical Devices, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection
Ekaterina Priezzheva, Deputy Minister of Industry and Trade of the Russian Federation
Alla Samoylova, Head, Federal Service for Surveillance in Healthcare (Roszdravnadzor)
Evgeniya Shapiro, Director General, PSK Pharma
Tadzio Schilling, Chief Executive Officer, Association of European Businesses (АЕВ)
Evgeny Shlyakhto, General Director, Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation
Tatyana Yakovleva, First Deputy Head, Federal Medical-Biological Agency of the Russian Federation